Use of smokeless tobacco and risk of myocardial infarction and stroke: systematic review with meta-analysis

Paolo Boffetta, Kurt Straif, Paolo Boffetta, Kurt Straif

Abstract

Objective: To assess whether people who use smokeless tobacco products are at increased risk of myocardial infarction and stroke.

Design: Meta-analysis of observational studies from Sweden and the United States.

Data sources: Electronic databases and reference lists.

Data extraction: Quantitative estimates of the association between use of smokeless tobacco products and risk of myocardial infarction and stroke among never smokers.

Review methods: Both authors independently abstracted risk estimates and study characteristics. Summary relative risks were estimated on the basis of random effects models.

Results: 11 studies, mainly in men, were included. Eight risk estimates were available for fatal myocardial infarction: the relative risk for ever use of smokeless tobacco products was 1.13 (95% confidence 1.06 to 1.21) and the excess risk was restricted to current users. The relative risk of fatal stroke, on the basis of five risk estimates, was 1.40 (1.28 to 1.54). The studies from both the United States and Sweden showed an increased risk of death from myocardial infarction and stroke. The inclusion of non-fatal myocardial infarction and non-fatal stroke lowered the summary risk estimates. Data on dose-response were limited but did not suggest a strong relation between risk of dying from either disease and frequency or duration of use of smokeless tobacco products.

Conclusion: An association was detected between use of smokeless tobacco products and risk of fatal myocardial infarction and stroke, which does not seem to be explained by chance.

Conflict of interest statement

Competing interests: None declared.

Figures

https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4787574/bin/bofp576439.f1_default.jpg
Fig 1 Strategy for selection of studies in meta-analysis
https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4787574/bin/bofp576439.f2_default.jpg
Fig 2 Forest plot of risk estimates for fatal myocardial infarction among users of smokeless tobacco products
https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4787574/bin/bofp576439.f3_default.jpg
Fig 3 Forest plot of risk estimates for fatal stroke among users of smokeless tobacco products

References

    1. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Vol 89. Smokeless tobacco products. Lyon: IARC, 2008.
    1. Rodu B, Godshall WT. Tobacco harm reduction: an alternative cessation strategy for inveterate smokers. Harm Reduct J 2006;3:37.
    1. Broadstock M. Systematic review of the health effects of modified smokeless tobacco products. NZHTA Report 2007;10:1-129.
    1. SCENIHR (Scientific Committee on Emerging and Newly-Identified Health Risks). Scientific opinion on the health effects of smokeless tobacco products. Brussels: European Commission, 2008. .
    1. Lee PN. Circulatory disease and smokeless tobacco in Western populations: a review of the evidence. Int J Epidemiol 2007,36:789-804.
    1. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology. A proposal for reporting. JAMA 2000;283:2008-12.
    1. Huhtasaari F, Asplund K, Lundberg V, Stegmayr B, Wester PO. Tobacco and myocardial infarction: is snuff less dangerous than cigarettes? BMJ 1992;305:1252-6.
    1. Huhtasaari F, Lundberg V, Eliasson M, Janlert U, Asplund K. Smokeless tobacco as possible risk factor for myocardial infarction: a population-based study in middle-aged men. J Am Coll Cardiol 1999;34:1784-90.
    1. Accortt NA, Waterbor JW, Beai C, Howard G. Chronic disease mortality in a cohort of smokeless tobacco users. Am J Epidemiol 2002;156:730-7.
    1. Asplund K, Nasic S, Janlert U, Stegmayr B. Smokeless tobacco as a possible risk factor for stroke in men. A nested case-control study. Stroke 2003;34:1754-9.
    1. Henley SJ, Thun MJ, Connell C, Calle EE. Two large prospective studies of mortality among men who use snuff or chewing tobacco. Cancer Causes Control 2005;16:347-58.
    1. Hergens MP, Ahlbom A, Andersson T, Pershagen G. Swedish moist snuff and myocardial infarction among men. Epidemiol 2005;16:12-6.
    1. Haglund B, Eliasson M, Stenbeck M, Rosén M. Is moist snuff use associated with excess risk of IHD or stroke? A longitudinal follow-up of snuff users in Sweden. Scan J Publ Health 2007;35:618-22.
    1. Hergens MP, Alfredsson L, Bolinder G, Lambe M, Pershagen G, Ye W. Long-term use of Swedish moist snuff and the risk of myocardial infarction among men. J Intern Med 2007;262:351-9.
    1. Wennberg P, Eliasson M, Hallmans G, Johansson L, Booman K, Jansson JH. The risk of myocardial infarction and sudden cardiac death amongst snuff users with or without a previous history of smoking. J Intern Med 2007;262:360-7.
    1. Hergens MP, Lambe M, Pershagen G, Terent A, Ye W. Use of smokeless tobacco and the risk of stroke among Swedish men. Epidemiol 2008;19:794-9.
    1. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
    1. StataCorp LP. Intercooled Stata 9.1 for Windows. College Station, TX: StataCorp, 2005.
    1. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-101.
    1. Greenland S, O’Rourke K. Meta-analysis. In: Rothman KJ, Greenland S, Lash TL, eds. Modern epidemiology, 3rd edn. Philadelphia, Pa: Lippincott Williams & Wilkins, 2008:652-82.
    1. Giovino GA, Schooley MW, Zhu BP, Chrismon JH, Tomar SL, Peddicord JP, et al. Surveillance for selected tobacco-use behaviors—United States, 1900-1994. MMWR CDC Surveill Summ 1994;43:1-43.
    1. Folkhälsa. Lägesrapport 2005. Stockholm: Socialstyrelsen, 2006:24. .
    1. World Health Organization. Mortality database. Geneva: WHO, 2008. .
    1. Rothman KJ, Greenland S. Precision and validity in epidemiologic studies. In: Rothman KJ, Greenland S, eds. Modern epidemiology, 2nd edn. Philadelphia, PA: Lippincott-Raven, 1998:115-34.
    1. Critchley JA, Unal B. Is smokeless tobacco a risk factor for coronary heart disease? A systematic review of epidemiological studies. Eur J Cardiovasc Prev Rehabil 2004;11:101-12.
    1. Tomar SL. Is use of smokeless tobacco a risk factor for cigarette smoking? The U.S. experience. Nicotine Tob Res 2003;5:561-9.
    1. Rodu B, Stegmayr B, Nasic S, Asplund K. Impact of smokeless tobacco use on smoking in northern Sweden. J Intern Med 2002;252:398-404.
    1. Stegmayr B, Eliasson M, Rodu B. The decline of smoking in northern Sweden. Scand J Public Health 2005;33:321-4.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться